// App-Quantinova.ai

PB2486 : E-selectin Inhibitor Is Superior to LMWH for Treatment of Experimental Venous Thrombosis

Researchers

Presenter

  • D. Myers

Principal Investigators

  • J.-J. Ning

  • P. Lester

  • R. Adili

  • A. Hawley

  • L. Durham

  • V. Dunivant

  • G. Reynolds

  • K. Crego

  • S. Sood

  • R. Sigler

  • W. Fogler

  • J. Magnani

  • M. Holinstat

  • T. Wakefield

Medical Centers

  • University of Michigan Medical School, Ann Arbor, Michigan, United States

  • The First Affiliated Hospital of Sun Yat‐sen University, Division of Vascular Surgery, Guangzhou, China

  • GlycoMimetics, Inc., Gaithersburg, United States

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • E-selectin

Drug/Treatment

  • Fibrinogen (IV)

  • GMI1271

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved